Recherche
-
Impact of the COVID-19 pandemic and its control measures on cardiovascular and antidiabetic drugs use in France in 2020: a nationwide repeated cohort study
(European Journal of Epidemiology. pp. 1-11, 2022-09-21)Article de revue -
Use of cardiovascular and antidiabetic drugs during COVID19 epidemic in France
(Fundamental & Clinical Pharmacology. vol. 36, n° S1, pp. 94-95, 2022-06)Article de revue -
Risk of first ischemic stroke and use of antidopaminergic antiemetics: A nationwide case-time-control study
(Fundamental and Clinical Pharmacology. vol. 36, pp. 22-23, 2022-06)Article de revue -
Risk of first ischaemic stroke and use of antidopaminergic antiemetics: nationwide case-time-control study
(BMJ. vol. 376, 2022-03-23)Article de revueLibre accès -
Chronic polypharmacy at all age: a population-based drug utilization study
(Fundamental and Clinical Pharmacology. vol. 36, n° 2, pp. 405-413, 2022-04)Article de revue -
Systematic review on sex differences for drug use after stroke
(Fundamental and Clinical Pharmacology. vol. 36, pp. 111-111, 2022-06)Article de revue -
Evaluation of Covid-19 vaccines: Pharmacoepidemiological aspects
(Thérapie. vol. 76, n° 4, pp. 305-309, 2021-05-07)Article de revue -
GLP-1 Receptor Agonists and the Risk of Thyroid Cancer
(Diabetes Care, 2022-11-10)Article de revue -
Bleeding risk with concurrent use of anticoagulants and ibrutinib: A population-based nested case-control study
(British Journal of Haematology. vol. 203, n° 2, pp. 311-318, 2023-10-01)Article de revue -
Drug-Drug Interactions and the Risk of Emergency Hospitalizations: A Nationwide Population-Based Study
(Drug Safety. vol. 46, n° 5, pp. 449-456, 2023-05)Article de revue